Vanguard Capital Management’s Alamar Biosciences ALMR Stock Holding History

Vanguard Capital Management’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6M	Buy	+463,385	New	+$10.5M	﹤0.01%	2698

Other funds holding ALMR

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management's ALMR Position: Q2 2026 in Review

Vanguard Capital Management opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 463,385 shares worth $12.6M. The stake represents ﹤0.01% of the portfolio and ranks #2698 among its holdings.

40 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

Vanguard Capital Management held 463,385 shares of Alamar Biosciences worth $12.6M as of Q2 2026.
Alamar Biosciences was a new Vanguard Capital Management position in Q2 2026.
Alamar Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2698 holding.
40 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.